Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
- 29 July 2000
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 356 (9227), 373-378
- https://doi.org/10.1016/s0140-6736(00)02528-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The validation of surrogate endpoints in meta-analyses of randomized experimentsBiostatistics, 2000
- Faster Access to Drugs for Serious or Life-Threatening Illnesses Through use of the Accelerated Approval Regulation in the United StatesDrug Information Journal, 1998
- Reappraisal of Hepatic Arterial Infusion in the Treatment of Nonresectable Liver Metastases From Colorectal CancerJNCI Journal of the National Cancer Institute, 1996
- Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α TherapyAnnals of Internal Medicine, 1995
- Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and aids researchStatistics in Medicine, 1994
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1993
- Treatment of Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1993
- Statistical validation of intermediate endpoints for chronic diseasesStatistics in Medicine, 1992
- Reporting Results From Chemotherapy TrialsJAMA, 1984
- Comparing survival of responders and nonresponders after treatment: A potential source of confusion in interpreting cancer clinical trialsControlled Clinical Trials, 1983